ACM
ELV icon

Ativo Capital Management’s Elevance Health ELV Stock Holding History

Ativo Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,193
Closed -$456K – 129
2021
Q2 		$456K Sell
1,193
-55
-4% -$21K 0.19% 119
2021
Q1 		$448K Sell
1,248
-382
-23% -$123K 0.19% 118
2020
Q4 		$523K Buy
1,630
+667
+69% +$205K 0.23% 114
2020
Q3 		$259K Buy
963
+197
+26% +$53K 0.12% 110
2020
Q2 		$202K Buy
+766
New +$204K 0.11% 103

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ativo Capital Management's ELV Position: Q3 2021 in Review

Ativo Capital Management sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 1,193 shares — an estimated $456K sold.

Ativo Capital Management first reported a position in ELV in Q2 2020 and held it in 5 quarters. The position peaked at $523K in Q4 2020. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Ativo Capital Management reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
  • Ativo Capital Management sold 1,193 Elevance Health shares in Q3 2021, an estimated $456K.
  • Ativo Capital Management first reported a position in Elevance Health in Q2 2020 and held it in 5 quarters.
  • Ativo Capital Management's Elevance Health position peaked at $523K in Q4 2020.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Ativo Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.